Fibrinogen concentrates for post-partum haemorrhage? Do not miss the most relevant population!

British Journal of Anaesthesia

Volumn 114, Issue 4, 2015, Pages 548-550

  Ickx, B ^a   Samama, C M ^b  

^a ERASME HOSPITAL   (Belgium)

^b Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN CONCENTRATE; PLACEBO; FIBRINOGEN;

BLEEDING; BLOOD CLOTTING DISORDER; DISEASE COURSE; EDITORIAL; ERYTHROCYTE TRANSFUSION; HEMOSTASIS; HUMAN; MORBIDITY; MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; VISCOELASTICITY; FEMALE; PREGNANCY;

FEMALE; FIBRINOGEN; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84926638213     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev033     Document Type: Editorial

References (24)

1. Girard T, Mörtl M, Schlembach D. Newapproaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm. Curr Opin Anaesthesiol 2014; 27: 267-74
2. Levy JH,Welsby I, Goodnough L. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54: 1389-405
3. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382
4. Hiippala ST, Myllylä GJ,Vahtera EM.Hemostatic factorsand replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5
5. de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20: 135-41
6. Rossaint R, Bouillon B, Cerny V, et al. The STOP the Bleeding campaign. Crit Care 2013; 26: 136
7. Dempfle CE, Kalsch T, ElmasE, et al.Impact of fibrinogenconcentration in severely ill patients on mechanical properties of whole blood clots. Blood Coagul Fibrinolysis 2008; 19: 765-70
8. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102: 793-9
9. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth 2013; 22: 87-91
10. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
11. Yamada T, Akaishi R, Oda Y, et al. Antenatal fibrinogen concentrations and postpartum haemorrhage. Int J Obstet Anesth 2014; 23: 365-70
12. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 2010; 19: 218-23
13. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentratecompared with cryoprecipitate in majorobstetrichaemorrhage-an observational study. Transfus Med 2012; 22: 344-9
14. Kikuchi M, Itakura A, Miki A, Nishibayashi M, Ikebuchi K, Ishihara O. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J Obstet Gynaecol Res 2013; 39: 770-6
15. Wikkelsø AJ, Edwards HM, Afshari A, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: a randomised controlled trial. Br J Anaesth 2015; 114: 623-33
16. Wikkelsø A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev 2013; 8: CD008864. doi:10.1002/14651858.CD008864
17. Lunde J, Stensballe J, Wikkelsø A, Johansen M, Afshari A. Fibrinogen concentrate for bleeding-a systematic review. Acta Anaesthesiol Scand 2014; 58: 1061-74
18. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009; 116: 1097-102
19. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124: 1727-36
20. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47
21. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118: 40-50.
22. Erratum in: Anesthesiology 2013; 118: 1244
23. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, andblood transfusion in traumapatients with significant haemorrhage (CRASH-2): a randomised, placebocontrolled trial. Lancet 2010; 376: 23-32
24. Wikkelsø AJ, Hjortøe S,Gerds TA, MøllerAM,Langhoff-RoosJ. Prediction of postpartum blood transfusion-risk factors and recurrence. J Matern Fetal Neonatal Med 2014; 27: 1661-7